Pictor Holdings Secures $7.5M Bridge Financing Round

The funding, backed by existing investors, will be used to expand commercial partnerships, grow the company's platform and manufacturing capabilities, and support research across key human and animal health markets.

The bridge funding round brings Pictor's total funding to about $30 million. It follows strong commercial progress during the company's first year at its U.S. headquarters, where Pictor launched seven products, signed four strategic partnerships, and strengthened its leadership team by appointing Terry Kelly, PhD, as Chief Operating Officer and Tim Shannon as Chief Financial Officer.

Read More:CarbonSix Raises $40M in Series A Funding Led by DSC Investment

Pictor's proteomics platform, which includes PictArray®, PictImager®, and Pictorial© software, allows laboratories to analyze up to 20 protein targets from a single sample in less than two hours. The system is designed to simplify workflows, reduce costs, and provide affordable testing for pharmaceutical companies, reference laboratories, and animal health customers.

The funding will be used to expand platform development and manufacturing, grow Pictor's partner network, and support large translational studies across key markets. The company expects to begin licensing agreements with several partners over the next 12 to 18 months.

Pictor is also exploring a U.S.-based Series A funding round to support its next stage of growth. The company plans to further expand its commercial operations, technology platform and strategic partnerships, with the bridge funding helping strengthen its position ahead of that milestone.

"Proteomic assays should not be limited to the largest, most specialized settings. Pictor's platform is designed to make protein insights more accessible, practical, and economical, so more partners can use them to improve health and wellness for people and animals. By helping labs generate more information from a single sample with fewer consumables, we also see an opportunity to support One Health and sustainability goals as adoption scales, "said Jamie Platt, PhD, CEO and Co-founder, Pictor Holdings Inc.

"The continued support of our existing investors reflects confidence in both the platform and the commercial model we've built around it. This capital positions Pictor to accelerate partnerships and scale operations as we advance toward our Series A, "said Tim Shannon, CPA, Chief Financial Officer, Pictor Holdings Inc.

About Pictor Holdings

Founded in 2025, Pictor Holdings Inc. is a proteomics technology company headquartered in Carlsbad, California, with operations in New Zealand, Australia, and India. The company develops multi analyte protein testing solutions for human, and animal health research, helping laboratories and biopharma companies analyze more samples faster, and at a lower cost.

Read More:Appnigma AI Closes Pre-Seed Funding Round Led by BetaBoom